Explore the words cloud of the EPIRIN project. It provides you a very rough idea of what is the project "EPIRIN" about.
The following table provides information about the project.
|Coordinator Country||Turkey [TR]|
|Total cost||157˙845 €|
|EC max contribution||157˙845 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2015-05-01 to 2017-04-30|
Take a look of project's partnership.
Non-alcoholic fatty liver disease (NAFLD) is a rapidly growing clinical problem, affecting a third of the European population. The transition of hepatic fat accumulation to inflammation is the key event taking place in the progression of NAFLD. This is controlled by a number of inflammatory and immune pathways including the activity of Natural Killer (NK) and Natural Killer T (NKT) cells. Progression from hepatic lipid deposition to inflammation and cirrhosis also follows a substantially variable course. It has been estimated that less than 10% of patients develop end-stage liver disease. Individual variability for disease progression is partly controlled by environmental factors and genetic background. However, it is not known how immune and inflammatory pathways are orchestrated by epigenetic mechanisms. The project hypothesises that “NK and NKT cells are programmed into inflammatory state by epigenetic modifications in progression from fatty liver to inflammation”. In this project, histone modifications and DNA methylation will be studied by genome-wide and loci-specific approaches in NK and NKT cells purified from animal models of NAFLD and a prospectively-designed human NAFLD cohort. Reversibility of these modifications will be investigated following the regression of liver disease in animal models and after the implementation of lifestyle changes in humans. Lastly, the therapeutic potential of targeting histone modifying enzymes by short hairpin RNA and small molecule inhibitors in NK and NKT cells for modulating inflammatory response will be investigated. The project will be the first comprehensive study investigating cross-talking epigenetic mechanisms in NK and NKT cells in NAFLD.
|year||authors and title||journal||last update|
Timothy Hardy, Mujdat Zeybel, Christopher P Day, Christian Dipper, Steven Masson, Stuart McPherson, Elsbeth Henderson, Dina Tiniakos, Steve White, Jeremy French, Derek A Mann, Quentin M Anstee, Jelena Mann
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
published pages: 1321-1328, ISSN: 0017-5749, DOI: 10.1136/gutjnl-2016-311526
M?jdat Zeybel, Sezgin Vatansever, Timothy Hardy, Ay?eg?l Akder Sar?, Fulya Cakala?ao?lu, Arzu Avc?, Gemma Louise Zeybel, Ser?in Karah?seyino?lu, Matthew Bashton, John C. Mathers, Belk?s ?nsal, Jelena Mann
DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease
published pages: , ISSN: 1868-7075, DOI: 10.1186/s13148-016-0218-1
|Clinical Epigenetics 8/1||2019-07-24|
Gemma L. Zeybel, Jeffrey P. Pearson, Amaran Krishnan, Stephen J. Bourke, Simon Doe, Alan Anderson, Shoaib Faruqi, Alyn H. Morice, Rhys Jones, Melissa McDonnell, Mujdat Zeybel, Peter W. Dettmar, Malcolm Brodlie, Chris Ward
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation
published pages: 124-131, ISSN: 1569-1993, DOI: 10.1016/j.jcf.2016.07.004
|Journal of Cystic Fibrosis 16/1||2019-07-24|
MÃ¼jdat Zeybel, Saimir Luli, Laura Sabater, Timothy Hardy, Fiona Oakley, Jack Leslie, Agata Page, Eva Moran Salvador, Victoria Sharkey, Hidekazu Tsukamoto, David C.K. Chu, Uma Sharan Singh, Mirco Ponzoni, Patrizia Perri, Daniela Di Paolo, Edgar J. Mendivil, Jelena Mann, Derek A. Mann
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
published pages: 218-231, ISSN: 1525-0016, DOI: 10.1016/j.ymthe.2016.10.004
|Molecular Therapy 25/1||2019-07-24|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPIRIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EPIRIN" are provided by the European Opendata Portal: CORDIS opendata.
Shaping the European Migration Policy: the role of the security industryRead More
Natural Product-Inspired Therapies for Leishmaniasis and Chagas DiseaseRead More
Narrative, Writing, and the Teotihuacan Language: Exploring Language History Through Phylogenetics, Epigraphy and IconographyRead More